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NOVELTY STATEMENT 
 
1. Numerous studies have examined the longitudinal relationship between depression and 
diabetes complications but comprehensive evidence about the magnitude and direction is 
unavailable.  
2. The current study shows that the relationship between depression and diabetes 
complications appears bi-directional with depression being associated with an increased risk 
of developing incident macrovascular and microvascular complications, and diabetes 
complications increasing the risk of subsequent depression.  
3. The increase in risk of developing diabetes complications in depressed people (by 38% and 
33% for macrovascular and microvascular complications, respectively) is higher than the 
increase in risk of developing depression (by 9% and 24% for macrovascular and 
microvascular complications, respectively) in people with diabetes complications. 
Word count 109 
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ABSTRACT 
Aims. To conduct a systematic review and meta-analysis of longitudinal studies assessing the bi-
directional association between depression and diabetes macrovascular and microvascular 
complications. 
Methods. Embase, Medline, and PsycINFO databases were searched from inception through 27th 
November 2017. A total of 4,592 abstracts were screened for eligibility. Meta-analyses used 
multilevel random/mixed-effects models. Quality was assessed using the Newcastle-Ottawa scale.  
Results. 22 studies were included in the systematic review. 16 studies examined the relationship 
between baseline depression and incident diabetes complications, of which nine studies involving 
over 1 million participants were suitable for meta-analysis. Depression was associated with an 
increased risk for incident macrovascular (Hazard Ratio HR=1.38; 95%CI: 1.30-1.47) and 
microvascular disease (HR=1.33; 95%CI: 1.25-1.41). Six studies examined the association between 
baseline diabetes complications and subsequent depression, of which two involving over 230 000 
participants were suitable for meta-analysis. The results showed that diabetes complications 
increased the risk of incident depressive disorder (HR=1.14; 95%CI: 1.07-1.21). The quality 
analysis showed increased risk of bias notably in the representativeness of selected cohorts and 
ascertainment of exposure and outcome. 
Conclusions. Depression in people with diabetes is associated with an increased risk of incident 
macrovascular and microvascular complications. The relationship between depression and diabetes 
complications appears bi-directional. However, the risk of developing diabetes complications in 
depressed people is higher than the risk of developing depression in people with diabetes 
complications. The underlying mechanisms warrant further research. 
 
Key words: Type 1 Diabetes, Type 2 Diabetes, Depression, Diabetes complications, Systematic 
review, Meta-analysis 
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Introduction 
Diabetes mellitus is associated with long-term complications including microvascular and 
macrovascular disease. Prospective studies have also shown a significant bi-directional relationship 
between type 2 diabetes and depression.1,2 Meta-analytic evidence of longitudinal studies indicates 
that diabetes increases the risk of developing depression by approximately 25%,3,4 and that 
depression increases the risk of incident type 2 diabetes by 40-60%.2,3 
Depression not only increases emotional suffering among people with diabetes, it also is associated 
with elevated prevalence of diabetes complications.5,6 More specifically, a meta-analysis of 27 
studies focusing on the associations of depression with macrovascular complications (such as 
coronary artery disease), microvascular complications (diabetic retinopathy, neuropathy, 
nephropathy or end stage renal disease), and sexual dysfunction found a significant and consistent 
positive relationship.7 Effect sizes (correlations) were small to moderate, ranging between 0.17 and 
0.32 (overall effect size of 0.25) and were similar across type 1 and type 2 diabetes study samples. 
However, all included studies had a cross-sectional design, precluding the identification of 
directions and pathways. For example, similar to the longitudinal relationship between depression 
and diabetes, depression and diabetes complications may be related either bi-directionally 
(depression may increase the risk of incident diabetes complications and vice versa) or only uni-
directionally. 
Since the publication of that meta-analysis, a number of prospective population-based studies have 
examined the longitudinal relationships between depression and diabetes complications. However, 
comprehensive analysis of the magnitude and direction of these relationships is unavailable. 
Therefore, the aim was to examine the directional relationships between depression and diabetes 
macrovascular and microvascular complications by conducting a systematic review of longitudinal 
epidemiological studies. Where possible, meta-analyses were carried out to quantify the size of the 
associations. 
METHODS 
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Data Sources and Searches  
This study is reported according to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA).8 Literature searches were conducted using Embase, Medline and 
PsycInfo from inception through 27th November 2017, including references of eligible articles. 
Databases were searched using Medical Subject Headings (MeSH) and Boolean operators. The 
search terms (for Embase see Supplementary Text 1) were adapted to meet the requirements of each 
database.  
Study Selection 
The results of the searches were divided into batches of 500, and for each batch two authors 
independently screened the titles and abstracts. Selected papers were retrieved and two other 
authors independently scrutinised the full text papers for inclusion. Disagreements were solved by 
discussion between the authors and the first author (AN). 
Articles meeting the following study criteria were included: a) involving adults (over 18 years old) 
at the time of follow-up with type 1 or type 2 diabetes mellitus; b) published in peer-reviewed, 
English language journals; c) examining the longitudinal relationship between depression and at 
least one long-term complication of type 1 or type 2 diabetes. Diabetes complications included 
microvascular diseases (retinopathy, neuropathy, nephropathy, sexual dysfunction or diabetic foot) 
and macrovascular diseases (angina, stroke, coronary artery disease, myocardial infarction, or 
peripheral vascular disease). Studies solely focusing on amputations related to diabetes 
complications (k=7) and studies examining the relationship between depression, diabetes and 
cardiovascular mortality were not included as these have been the topic of recent systematic 
review/meta-analyses.9,10 Moreover, amputations reflect treatment decisions, which may confound 
their relationship with depression. Studies were also excluded if they focused on gestational 
diabetes, impaired glucose tolerance, or pre-diabetes. Studies examining the relationship of diabetes 
complications with either lifetime or current depression were included. 
Data Extraction and Quality Assessment 
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One author (AN) performed data extraction, which was verified by two other authors (MA, MI). 
Data of interest included: 1) name of first author; 2) publication year; 3) country; 4) study design; 
5) number of participants; 6) mean age/age range; 7) gender; 8) diabetes type; 9) diabetes duration; 
10) follow–up length; 11) depression assessment method; 12) diabetes assessment method; 13) 
diabetes complications assessment method; 14) results regarding associations between depression 
and diabetes complication(s). 
Method of depression assessment could be either a diagnosis of depression assessed by a diagnostic 
psychiatric interview or assessment of depressive symptoms using a self-report questionnaire. Type 
of diabetes and diabetes complications could be assessed either via self-report or extracted from 
medical records. Diabetes complications could be assessed either via self-report, or with the use of 
diagnostic tests, or extracted from medical records. 
Quality assessment of included studies was conducted by two authors (AN, KvD) based on the 
Newcastle-Ottawa scale11 for cohort studies. Three domains were evaluated for each study: 
selection of the study groups, comparability of the groups and ascertainment of outcome of interest 
(see Table 1). There were three levels of evidence: low risk of bias (a score of 7-9), moderate risk 
of bias (5-6), and high risk of bias (score < 5).12 
Data Synthesis and Analysis 
The meta-analysis used multilevel random/mixed-effects models with random effects for studies 
and estimates within studies, which accounts for the dependency in the underlying true effects for 
studies supplying multiple estimates (in some studies, the same participants were assessed for 
multiple macrovascular and microvascular outcomes). Although correlation in the sampling errors 
is not automatically considered in this model, theoretical considerations and simulation studies13 
have shown that the multilevel model automatically subsumes this source of dependency into the 
correlation between the true effects and therefore provides valid inferences about the fixed effects. 
As a sensitivity analysis, we also used cluster-robust inference methods13,15 which yielded identical 
conclusions.   
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Criteria for meta-analysis were outcomes reported as proportional hazard ratios (HR) and 95% 
confidence intervals (95%CI). For some studies, to obtain the estimate of interest (e.g. reference 
group people with diabetes and no depression versus people with diabetes and depression), we 
recalculated HR using the procedures described in Van Dooren et al.9 For Black et al.16 we 
combined the HR for the group of participants with diabetes without any depressive symptoms 
(CES-D=0) and those with diabetes with minimal depression (CES-D=1-15) into the reference 
group. For Lin et al.,17 we combined the groups with probable minor depression (PHQ-9 algorithm) 
and no depression into the reference group and compared them with the group with probable major 
depression (PHQ-9 algorithm). For Scherrer et al.,18 we used the information from the four-group 
scenario (neither diabetes nor MDD, MDD alone, type 2 diabetes alone, and comorbid MDD and 
type 2 diabetes) to obtain the HR for the comparison of the two diabetes groups. For the meta-
analyses, all outcome variables were dichotomized. 
RESULTS 
Search results 
Figure 1 shows the results of the selection process. The searches yielded 7,457 potential articles. 
After removing conference papers, books, dissertation abstracts and duplicates within or between 
the databases, 4,591 abstracts remained. Twenty-nine eligible papers were selected, 24 from 
EMBASE and 5 additional papers from Medline (no additional papers from PsycInfo). One of the 
authors identified an additional paper19 not included in the search results, bringing the total to 30 
papers. Searches of the reference lists did not identify additional potential papers. The extracted 
data of the 30 studies are presented in Supplementary Tables 1a-1c. 
Where more than one study relied on the same cohort [six papers from the Epidemiological 
Diabetes Cohort (EDC) Study,20–25 four from the Pathways Epidemiological Study17,26–28], only the 
most recent or the most complete study17,23 was selected for the review, resulting in 22 papers being 
included in the systematic review. Of those, 16 papers including 1,025,563 people with diabetes 
examined the relationship of depression to incident diabetes complications (see Supplementary 
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Tables 1a,b), while six studies including 239,519 people with diabetes examined the relationship of 
diabetes complications to incident depression (see Supplementary Table 1c). Data came 
predominantly from the USA but also from Canada, China, Italy, Norway, Taiwan, Germany, UK, 
and the Netherlands. 
Three of the 22 studies examined people with type 1 diabetes mellitus,23,29,30 nine examined people 
with type 2 diabetes mellitus,16-19,32–36, and six studies examined people with either type of diabetes 
mellitus.31,37–41 Four studies did not specify the type of diabetes.42–45 
Twelve studies quantified the results in terms of Cox proportional hazard ratios16-19,31–34,38,41,42,45, 
others used odds ratios,29,30,36,40,43,44 relative risk37, or provided regression coefficients.39 Two 
papers briefly explained that depression did not increase incident diabetes complications but did not 
report the numerical details.23,35 Of the 12 studies reporting Cox proportional hazard ratios, 10 
studies concerned depression as a risk factor for the onset of diabetes complications and two studies 
concerned the relationship from diabetes complications to incident depression.  
Depression as a risk factor for diabetes complications 
Finally, nine studies of the ten studies reporting HR and 95% CI were suitable for meta-analysis; 
one study was not suitable for inclusion because a continuous depression measure was used rather 
than dichotomised depression.41 Nine studies allowed for a meta-analysis testing depression as a 
risk factor for macrovascular disease. Four of the nine studies had provided data on depression as a 
risk factor for microvascular complications, which could be used in an additional meta-analysis. Of 
the nine studies16-19,31–33,38,45, most used a composite macrovascular outcome including conditions 
such as myocardial infarction, coronary artery disease, congestive heart failure, stroke, but some 
also included cardiovascular procedures (e.g. percutaneous coronary artery intervention, coronary 
artery bypass grafting, abdominal aortic aneurysm repair, and revascularization of the lower 
extremity16) or unstable angina32 to obtain a single estimate of macrovascular disease. However, 
one study31 reported separate outcomes for stroke and coronary heart disease for the same sample, 
which were included individually.  
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Of the four studies also analyzing microvascular complications,16,17,31,32 three studies included a 
composite microvascular outcome,16,17,32 while Novak et al.31 only used incident chronic kidney 
disease as an outcome.  
To examine whether the HR of developing complications in people with diabetes and depression 
differed according to the type of complication (macro/micro), we first carried out a moderator 
analysis. The results showed that the relation between depression and complication development 
did not differ according to type of complication [χ2(1)=0.67, p=0.41], allowing us to analyse an 
overall measure of complications. 
In this initial analysis, those with depression were on average 51% more likely to develop a 
complication than those without depression (HR=1.51; 95%CI: 1.23-1.86). A forest plot of the HR 
and 95%CI of each study, together with the estimated overall HR based on all estimates combined, 
is shown in Fig. 2. 
However, there was considerable heterogeneity between studies [Cochran's Q(13)=92.30, p<0.001; 
I2=86%]. Standardized residuals and Cook's distances showed that Black et al.16 was an influential 
study and the source of the heterogeneity in these data (primarily due to a much larger effect size 
than other studies for microvascular disorders). This study was also the only study in the initial 
meta-analysis where complications were based on self-report; therefore, we repeated the above 
analyses without its inclusion and regard these results as our study’s primary findings.  
Moderator analysis of complication type was significant for these 11 studies [χ2(1)=18.82, 
p<0.001]; therefore results are reported separately for macrovascular and microvascular 
complications. Depression was associated with an increased risk of macrovascular (HR=1.38; 
95%CI: 1.30-1.47) and microvascular (HR=1.33; 95%CI: 1.25-1.41) complications (see Fig. 2). 
Sensitivity analyses using the cluster-robust inference approach yielded identical conclusions in all 
analyses reported above. 
A number of studies (k=7) identified in the systematic review reported incompatible statistics and 
could not be included in the meta-analysis (e.g. odds ratios instead of hazard ratios; for details, see 
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Supplementary Table 1). In terms of macrovascular complications, results of two studies supported 
the findings of the meta-analysis.29,36 Another study23 found a significantly increased risk only for 
angina (HR=1.40; 95%CI: 1.06-1.84), but not for objective CAD (no statistics were provided for 
the latter). In terms of microvascular complications, results were mixed, with three studies 
supporting30,41,43 and two failing to support the findings of the meta-analysis.35,36 Regarding incident 
foot ulcers, one study found that there was a linear relationship between increased risk and severity 
of depressive symptoms.43 
Diabetes complications as a risk factor for depression 
Six studies examined the hypothesis that diabetes complications increase the risk of incident 
depression.34,37,39,40,42,44 For the two largest of these studies (combined N = 234,628) nine HRs of 
diagnosed depression were suitable for meta-analysis.34,42 Therefore, we tested whether any 
diabetes complication increased the risk of incident depressive disorder. Therefore, we tested 
whether any diabetes complication increased the risk of incident depressive disorder. Results 
showed that diabetes complications increased the risk of incident depressive disorder (HR=1.14; 
95%CI: 1.07-1.21). Analysis using the cluster-robust approach confirmed these results. Because 
moderator analysis of complication type was significant [χ2(1)=3.91, p=.048], we report the results 
of the meta-analysis separately for macrovascular and microvascular complications. Both 
macrovascular complications (HR=1.09; 95%CI: 1.02-1.17) and microvascular complications 
(HR=1.24; 95%CI: 1.12-1.37) were associated with an increased risk of depressive disorder.  
For a Forest plot, see Fig. 3. 
The remaining four studies37,39,40,44 reported statistics incompatible with their inclusion in the meta-
analysis (e.g. odds ratios or relative risks instead of hazard ratios; for details, see Supplementary 
Table 1-c). One study44 found that diabetes complications (not specified) increased the odds of 
developing depressive symptoms (OR=1.46 (95%CI 1.14–1.86). The results of the three studies that 
did look at specific diabetes complications mimicked those of the two studies in the meta-analyses. 
Regarding macrovascular complications, one study37 found an increased risk of depressive 
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symptoms with coronary artery disease, cerebral vascular disease and peripheral vascular disease, 
while another study40 found this to be the case for macrovascular events or procedures but not for 
stroke. Regarding microvascular complications, one study40 found no significant increased risk of 
depressive symptoms with either retinopathy or nephropathy. Two other studies37,39 found an 
increased risk of depressive symptoms with neuropathy, but not with retinopathy or foot problems37. 
For details, see Supplementary Table 1c). 
Quality of evidence 
Of the 22 included studies, two showed high risk of bias, eight showed moderate risk of bias and 12 
showed low risk of bias (see Table 1). Risk of bias was mainly due to the use of selected rather than 
representative cohorts (8/22 studies), use of self-report or failure to report use of secure records or 
structured interviews to ascertain exposure (15/22 studies) or outcome (9/22 studies), and failure to 
demonstrate that the outcome of interest (diabetes complications/depression) was not present at 
baseline (10/22 studies, although all but three studies36,38,45 statistically controlled for this). 
DISCUSSION 
This systematic review identified nine studies suitable for meta-analysis which showed that in 
people with diabetes, those with co-morbid depression have a 38% and 33% increase in risk of 
developing macrovascular and microvascular complications, respectively, compared to controls 
without depression. The systematic review also identified eight studies unsuitable for inclusion in 
the meta-analysis. For macrovascular complications, results of these studies generally concurred 
with those obtained in the meta-analysis, except for one study.23 For microvascular complications, 
results were mixed, with three studies supporting30,41,43 and two failing to support35,36 the findings of 
meta-analysis. Of the latter, one examined participants during their first two years of newly 
diagnosed diabetes,36 and the other had cognitive function as the main predictor variable.35 
Finally, six identified studies examined the relationship from diabetes complications to incident 
depression.34,37,39,40,42,44 In the meta-analysis of the two largest studies34,42 (total N = 234,628) 
diabetes complications increased the risk of developing depressive disorder by 14%. Although this 
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increase in risk was found to be higher for microvascular complications than for macrovascular 
complications (by 24% vs 9%, respectively), because of the small number of studies these results 
should be interpreted with caution. The results of the six studies not included in the meta-analyses 
(Supplementary Table 1c) mimic those of the meta-analysis and suggest that having macrovascular 
and microvascular diabetes complications may increase the risk of developing depression. However, 
across the six studies examining the relationship of diabetes complication as a risk factor for 
depression, we did not find evidence of a systematic effect of specific complications.  
Taken together our results provide support for a bi-directional relationship between diabetes 
complications and depression. In other words, depression (both depressive symptoms and major 
depressive disorder) increases the risk of incident macrovascular and microvascular diabetes 
complications, and the presence of diabetes complications increases the risk of significant 
depressive symptoms and/or possible depressive episode. However, the increase in risk of 
developing diabetes complications (by 38% and 33% for macro and micro-vascular complications, 
respectively) in depressed people is higher than the increase in risk of developing depression (by 9% 
and 24% for macro and micro-vascular complications, respectively) in people with diabetes 
complications. These findings parallel those found for the bi-directional longitudinal relationships 
between diabetes and depression with a modest increased relative risk (15%) of developing 
depression in people with diabetes and a higher relative risk (60%) for the development of diabetes 
in depressed people.2  
These findings may reflect different underlying mechanisms for the relationship from depression to 
diabetes or diabetes complications than for the relationship from diabetes or diabetes complications 
to depression. While the exact nature of these underlying mechanisms remains unknown, there are a 
number of common processes that may result in these negative outcomes. First, depression is often 
accompanied by behavioural changes including reduced self-care and medication adherence46, 
increased smoking, reduced physical activity and increased sedentary behaviours, and increased 
intake of high calorie food.47 These behaviours may be particularly problematic in the context of 
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diabetes and are likely to adversely affect glycaemic control, which, in turn is associated with 
increased risk of complications48. Moreover, the UKPDS has shown that a 1% in reduction in 
HbA1c may delay the onset of diabetes complication by 21%.49 However, studies found no 
evidence that depression delays insulin initiation.50,51 
More recently, biological processes associated with obesity, insulin resistance, and persistent poor 
glucose control have been implicated in the development of diabetes complications in the context of 
depression. More specifically, inflammatory processes associated with both diabetes and 
depression52 have been identified as possible mechanisms.53 Other studies have shown that 
depression and diabetes is associated with endothelial function, increasing the risk of macrovascular 
disease54 although underlying mechanisms are yet to be elucidated.  
The mechanisms underlying the increased risk of incident depression as a result of diabetes 
complications are likely to be similar to those hypothesised for diabetes as a risk for depression 
onset. Although inflammation and other biological factors may play a role,52,54 the epidemiological 
evidence points to the role of diabetes burden and distress as contributing factors.55,56 The results of 
our study showing no systematic effect of specific diabetes complications is consistent with the 
latter. It should be noted that only one study39 examining the relationship of complications with 
incident depression controlled for pain as a possible contributor.  
Overall, the results of the current study extend the findings of a previous systematic review/meta-
analysis of cross-sectional studies7 and shows that depression is associated with increased risk of 
diabetes complications. Importantly, given that depression is a treatable condition, the clinical 
implication of this study is that depression could be a preventable risk factor for diabetes 
complications. Future studies are needed to examine whether intensive and successful treatment of 
depression in diabetes does indeed reduce the risk of future complications.57   
The current study also adds to an increasing number of longitudinal studies showing that depression 
in diabetes, even when using self-report questionnaires, can have serious consequences including 
reduced self-care,39 increased cognitive decline,58 dementia,59 and mortality.9  
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A number of limitations should be taken into consideration when interpreting the results of this 
study. First, despite the large number of participants on which the meta-analyses were based, the 
relatively small number of studies available (k=9 for the relationship from depression to diabetes 
complications and k=2 for the relationship from diabetes complications to depression) precluded 
examination of the contribution of factors such as specific diabetes complications, type of 
depression measurement, and type of diabetes. Moreover, although some studies included 
participants with type 1 diabetes with paediatric onset, teasing out the effects of depression on 
diabetes complications in type 1 versus type 2 diabetes remains a topic for future research. 
Second, the quality assessment of the included studies found high risk of bias in two studies due to, 
among other factors, the use of self-report measures to ascertain exposure or outcome. Self-report 
should be avoided when objective diagnostic tests are available, such as in the case of diabetes 
complications. However, as there are no known biomarkers for depression, its assessment remains 
based on symptomatology; although structured diagnostic interviews are considered the gold 
standard for identifying depression, self-report symptom questionnaires are commonly used. While 
the use of questionnaires may be considered as introducing bias, research suggests that symptom 
questionnaires and diagnostic interviews assess different constructs, with elevated depressive 
symptoms more reflective of general and diabetes-specific emotional distress than of clinical 
depression.60 Furthermore, although most studies provided follow-up data, only a few studies 
provided information as to how many people had died from diabetes complications during the 
follow-up period. Because mortality is higher in people with depression, it is likely that the results 
from the meta-analysis are conservative. Third, the included studies did not provide information 
regarding the specific set of complications individuals developed during the study. It is therefore 
impossible to ascertain whether depression leads to the development of only single complications 
or a cluster of complications. Furthermore, some of the studies in the meta-analysis17,31–33 included 
not only diabetes complications but also surgical interventions, which may or may not have resulted 
from the onset or worsening of diabetes complications and may have confounded the observed 
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relationships. Fourth, it is unclear how clinical management, access to medical care, disease 
management supplies and medications, financial burden of diabetes, and other socioeconomic 
factors play into the development of depression or diabetes complications and the relationship 
between the two.  
In summary, depression in people with diabetes is associated with an increased risk of incident 
macrovascular and microvascular complications. This relationship is likely to be bi-directional as 
diabetes complications were also found to increase the risk of incident depression. It remains to be 
determined whether effective treatment of depression reduces the risk of developing diabetes 
complications. 
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Table 1. Results of quality assessment of studies identified in the systematic review, based on the 
Newcastle Ottawa- scale 
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Depression to Diabetes Complications 
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♯EPESE cohort 
§ EDC cohort  
¶ Pathways cohort 
*Baltimore, State College and Manchester Hospital cohorts 
- Retrospective analyses 
For a summary and scoring of the Newcastle-Ottawa scales see Supplementary Text 2.  
 
 
 
 
  
Figure legends 
 
Figure 1. Flow chart of study selection process. 
 
Figure 2. Forest Plot of hazard ratios of longitudinal studies included in the meta-
analysis examining associations from baseline depression to incident diabetes 
complications, grouped by macrovascular complications and microvascular 
complications. 
 
Note: CAD=Coronary artery disease; CHD=coronary heart disease; 
CVD=cerebrovascular disease; MI=myocardial infarction; PVD=Peripheral vascular 
disease. 
 
 
Figure 3. Forest Plot of hazard ratios of longitudinal studies included in the meta-
analysis examining associations from baseline diabetes complications, grouped by 
macrovascular complications and microvascular complications, to incident 
depression. 
 
Note: CHD=coronary heart disease; CVD=cerebrovascular disease; MI=myocardial 
infarction; PVD=Peripheral vascular disease. 
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through Embase 
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through PsycInfo 
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Records identified 
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Studies included 
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depression -> complications n=16 
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Studies included in the meta-
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Supplementary Text 1. Search criteria Embase 
 
Database: Embase <1974 to 2016 October 05> 
Search Strategy: 
1 diabetes/ or diabetes mellitus/co, di, px, ep (499874) 
2 "diabet*".ti,ab. (707014) 
3 1 or 2 (805841) 
4 "depression (emotion)"/ or major depression/co, di, px, ep (7361) 
5 "depress*".ti,ab. (482519) 
6 4 or 5 (483805) 
7 diabetes mellitus/ or diabetic angiopathy/ or diabetic cardiomyopathy/ or 
diabetic 
foot/ or diabetic hypertension/ or diabetic nephropathy/ or diabetic 
neuropathy/ or 
diabetic retinopathy/co, di, px, ep (594007) 
8 Diabetes Complications.mp. (3507) 
9 ("diabetic angiopath*" or "diabetic cardiomyopath*" or "diabetic foot" or 
"diabetic 
hypertension" or "diabetic neuropath*" or "diabetic nephropath*" or "diabetic 
retinopath*").ti,ab. (60658) 
10 7 or 8 or 9 (607118) 
11 exp Stroke/co, di, ep (17979) 
12 "strok*".ti,ab. (281326) 
13 11 or 12 (288429) 
14 exp Sexual Dysfunction/co, di, ep (11900) 
15 "sexual dysfunction*".ti,ab. (13800) 
16 14 or 15 (23491) 
17 exp Cerebrovascular disorders/co, di, ep (115603) 
18 exp cerebrovascular Disease/co, di, ep (115603) 
19 ("cerebrovascular diseas*" or "cerebrovascular disorder").ti,ab. (23494) 
20 exp heart infarction/co, di, ep (60551) 
21 "myocardial infarction*".ti,ab. (217248) 
22 17 or 18 or 19 or 20 or 21 (371363) 
23 10 or 13 or 16 or 22 (1165895) 
24 3 and 6 and 23 (14603) 
25 limit 24 to (human and English language and yr="1980 -Current" and adult 
<18 
to 64 years>) (5259) 
  
Supplementary Text 2.  Summary and scoring of the Newcastle-Ottawa scale 
 
SELECTION 
Representativeness of the exposed 
cohort 
a) truly representative of the average 
person with diabetes in the community * 
b) somewhat representative of the 
average person with diabetes in the 
community * 
c) selected group of users e.g. nurses, 
volunteers 
d) no description of the derivation of the 
cohort 
  
Selection of the non-exposed cohort 
a) drawn from the same community as 
the exposed cohort * 
b) drawn from a different source 
c) no description of the derivation of the 
non-exposed cohort 
  
Ascertainment of exposure (depression 
diagnosis / complications) 
a) secure record (e.g. surgical records) * 
b) structured interview * 
c) written self-report 
d) no description 
  
Demonstration that outcome of 
interest was not present at start of 
study 
a) yes * 
b) no 
  
COMPARABILITY 
Comparability of cohorts on the basis 
of the design or analysis 
i) study controls for 
complications/depression at baseline  
a) yes * 
b) no * 
ii) study controls for any additional 
factor a) yes * 
b) no   
 
 
 
 
 
OUTCOME 
Assessment of outcome 
a) independent blind assessment * 
b) record linkage * 
c) self-report 
d) no description 
  
Was follow-up long enough for 
outcomes to occur? 
Minimum follow-up time complications 
5 years 
Minimum follow-up time recurrence foot 
ulcers 18 months 
Minimum follow-up time depression 24 
months  
a) yes * 
b) no 
  
Adequacy of follow up of cohorts 
a) complete follow-up - all subjects 
accounted for * 
b) subjects lost to follow up unlikely to 
introduce bias - small number lost, >80% 
follow up, or description provided of 
those lost * 
c) follow up rate <80% and no 
description of those lost 
d) no statement
  
*The Newcastle-Ottawa Scale quality instrument is scored by awarding a point for each 
answer that is marked with an asterisk. Possible total points are 4 points for Selection, 2 
points for Comparability, and 3 points for Outcomes. 
 
Reference: Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. 
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies 
in meta-analyses. Ottawa Hosp Res Inst. 2013;(3):1-4. doi:10.2 
  
  
  
  
 
 
Supplementary Table 1A. Depression to macrovascular complications (Overview of all included studies sorted by publication date in ascending order) 
 
Author, year, 
country 
Follow-
up  
(years) 
Study design and 
population 
Baseline 
number of 
participants  
(mean age, sex, 
type of diabetes) 
 
Diabetes  
Duration 
(mean±SD) 
[range]  
years 
Depression 
assessment  
Diabetes 
assessment  
Complication assessment  Major findings 
 
Lloyd et al., 
1996, USA20  
 
4 Prospective 
cohort study 
recruited from 
Children’s 
Hospital of 
Pittsburg registry 
of IDDM 
(Pittsburgh 
Epidemiology of 
Diabetes 
Complications 
study (EDC)) 
 
634 (27 years, 
49% women, type 
1) 
 
19.0 ± 7.5 
 
 
BDI 
 
Hospital registry: 
childhood-onset 
(<17 years) 
IDDM and to be 
on insulin therapy 
at discharge 
CAD: Presence of angina 
(diagnosed by physician), 
a history of MI (confirmed 
by ECG or by review of 
medical records), or death 
due to CAD (by death 
certificate review) during 
the follow-up period 
For men, duration of IDDM, HDL 
cholesterol and nephropathy were 
independent predictors of CAD. For women, 
duration, hypertension, waist-hip ratio, 
physical activity, and depressive 
symptomatology were all independent 
predictors of CAD. 
 
Cox Proportional Hazards Model 
Standardised RR sex x depression=1.60 (SE 
0.01) p=0.053  
Orchard et 
al., 1999, 
USA22  
8 Nested Case-
control Study  
recruited from 
Children’s 
Hospital of 
Pittsburg registry 
of IDDM 
(Pittsburgh 
Epidemiology of 
Diabetes 
Complications 
study (EDC)) 
98: 49 cases + 49 
matched controls 
(34 years, 49% 
women, type 1) 
 
26.0 ± 6.4 BDI Hospital registry: 
childhood-onset 
(<17 years) 
IDDM and to be 
on insulin therapy 
at discharge 
CAD: Presence of angina 
(diagnosed by physician), 
a history of MI (confirmed 
by ECG or by review of 
medical records), or death 
due to CAD (by death 
certificate review) during 
the follow-up period 
 
Depression, hypertension, and log Ab-
OxLDL (antibodies to oxidized LDL) were 
independent predictors of CAD in 
multivariate analysis. 
 
Cox Proportional Hazards Model 
Depression: RR=1.5 (95%CI 1.45–1.54) 
Forrest et al., 
2000, USA24  
6 Prospective 
cohort study 
recruited from 
Children’s 
Hospital of 
Pittsburg registry 
of IDDM 
(Pittsburgh 
Epidemiology of 
Diabetes 
Complications 
658 (28 years, 
49% women, type 
1)  
20  BDI Hospital registry: 
childhood-onset 
(<17 years) 
IDDM and to be 
on insulin therapy 
at discharge 
CHD and LEAD: CHD, 
presence of angina 
(diagnosed by physician), 
a history of MI (confirmed 
by ECG or by review of 
medical records), or death 
due to CAD (by death 
certificate review) during 
the follow-up period. 
LEAD, an ankle-to-arm 
ratio < 0.9 at rest, a history 
Hypertension, low HDL cholesterol level, 
high white cell count, depression, and 
nephropathy were independent risk factors 
for CHD (including morbidity and mortality). 
Depressive symptoms did not predict LEAD. 
 
Cox Proportional Hazards Models 
Total CHD: BDI coefficient = 0.06 (SE 0.02; 
p =0.003)  
CHD morbidity: BDI coefficient = 0.07 (SE 
0.02; p = 0.003) 
  
study (EDC)) of claudication or 
amputation for vascular 
cause 
 
 
Kinder et al., 
2002, USA25  
10 Prospective 
cohort study 
recruited from 
Children’s 
Hospital of 
Pittsburg registry 
of IDDM 
(Pittsburgh 
Epidemiology of 
Diabetes 
Complications 
study (EDC)) 
 
525 (29 years, 
50% women, type 
1) 
20 
[8–37] 
BDI Hospital registry: 
childhood-onset 
(<17 years) 
IDDM and to be 
on insulin therapy 
at discharge 
CHD: Presence of angina 
(diagnosed by physician), 
coronary occlusion greater 
than 50% by angiography, 
coronary revascularisation, 
MI (confirmed by ECG or 
by review of medical 
records)  
 
Depressive symptoms predicted CHD in a 
sample of both men and women with type 1 
diabetes who were free of CHD at baseline. 
 
Cox Proportional Hazards Model 
All CHD: HR*=1.29 (95%CI 1.08–1.54) 
 
*Univariate 
Black et al., 
2003, USA16 
7 
 
5  
for 
“lifetim
e major 
depressi
on or 
dysthym
ia” 
Longitudinal 
population based 
study of Mexican 
Americans 
residing in the 
South Western 
USA (subgroup 
with diabetes) 
(Hispanic 
Established 
Population for the 
Epidemiologic 
study of the 
Elderly: EPESE) 
 
636 (≥ 65 years, 
% women n/a, 
type 2)  
 
“No depression” 
(CESD=0) 
n=79 
 
“Minimal 
depression” 
(CESD=1-15) 
n=369 
 
“Minor 
depression” 
(CESD≥16) 
n=188 
 
“Lifetime major 
depression or 
dysthymia” 
n=52/453 
 
n/a CES-D≥16 or 
clinical 
diagnostic 
criteria (CIDI), 
DSM-IV 
Self-report  CAD, stroke, kidney 
disease by self-report 
 
Compared to reference group of people 
without DM or depression, having T2DM 
and depression predicted increased incidence 
of macrovascular complications. 
 
Cox Proportional Hazards Models 
 
“Minimal depression”: HR*=1.56 (95%CI 
1.21–2.00) 
 
“Minor depression”: HR*=2.40 (1.71–3.36) 
 
“Lifetime major depression or dysthymia”: 
HR*=2.64 (95%CI 1.73–4.04)  
 
*Adjusted for age, sex, education, 
acculturation, marital status  
 
 
 
 
Orchard et 
al., 2003, 
USA23  
10 Prospective 
cohort study 
recruited from 
Children’s 
Hospital of 
Pittsburg registry 
of IDDM 
603 (28 years, % 
women n/a, type 
1) 
 
19 
(7–37) 
BDI scores Hospital registry: 
childhood-onset 
(<17 years) 
IDDM and to be 
on insulin therapy 
at discharge 
CAD: defined as MI 
confirmed by hospital 
records or ECG; angina 
diagnosed by an physician; 
angiographically proven  
stenosis defined as ≥50% 
blockage, or 
Depressive symptoms were an independent 
risk factor for angina, but did not predict hard 
CAD events (e.g. myocardial infarction) or 
total CAD (no data provided). 
 
Cox Proportional Hazard Model 
Angina: HR=1.40 (95%CI 1.06–1.84) 
  
(Pittsburgh 
Epidemiology of 
Diabetes 
Complications 
study (EDC)) 
 
revascularization; ischemic 
ECG 
 
 
Clouse et al., 
2003, USA38 
6 Prospective study 
of women diabetic 
subjects recruited 
as part of a series 
of investigations 
by the National 
Institutes of 
Health in 
Washington  
76 (41 years, 
100% women, 
type 1, type 2 
[55%]) 
 
No depression 
n=60 
 
Major depression 
n=16 
 
Depression  
13.1 ± 8.8 
 
No 
depression  
12.2 ± 7.8 
 
Mental Health 
Diagnostic 
Interview, 
DSM-III 
National Diabetes 
Data group 
criteria 
CHD, PVD, 
cerebrovascular disease 
(CVD): CHD, based on 
documented MI or 
ischemic 
electrocardiographic 
changes observed at rest or 
during an exercise 
treadmill test. PVD,  
history of claudication, 
pulseless lower extremity, 
or ischemic ulceration of a 
lower extremity.CVD by  
transient ischemic attacks 
or cerebrovascular 
accident 
Major depression was an independent risk 
factor that accelerated the development of 
CHD. Depression did not predict PVD or 
cerebrovascular diseases – data not 
presented. 
 
Cox Proportional Hazard Models 
HR*=6.67 (95%CI 1.26–35.23) 
HR**=5.2 (95%CI 1.4–18.9) 
 
*Univariate 
**Adjusted for age 
 
Roy et al., 
2007a, USA29 
6 Longitudinal 
study of African-
American  people 
with type 1 
diabetes admitted 
to hospitals in 
New Jersey 
 
483 (28 years, 
60% women, type 
1) 449 without 
evidence of CVD 
 
No depression, 
(BDI ≤ 14) 
n=264 
 
Depression 
(BDI >14) 
n=51 
10.4 ± 8.6 BDI>14 Medical records CVD: defined as CAD, 
either angina or MI and 
stroke by ICD-9 codes and 
ECG abnormalities 
Baseline older age, higher body mass index, 
higher diastolic blood pressure, 
proteinuria, retinopathy severity and being 
depressed were significant and independent 
risk factors for incidence of any CVD. 
 
Of 283 pts without baseline depression 
11.7% developed CAD or stroke. Of 94 with 
baseline depression 19.2% developed CAD 
or stroke. 
 
OR*=1.04 (95%CI 1.001–1.08) 
 
*Adjusted for age, diastolic BP, BMI, 
retinopathy 
 
Lin et al., 
2010, USA17¶ 
5 Longitudinal 
cohort study of 
primary care 
people with type 2 
diabetes in 
Western 
Washington state, 
USA (Pathways 
Epidemiology 
3,723 (64 years, 
48% women, type 
2) 
 
No depression: 
n=2965 
 
Minor depression: 
n=315 
8.8 ± 8.4 
 
PHQ-9 
algorithm 
 
Minor 
depression:  
2-4 positive 
symptoms 
including 1 core 
symptom 
In the preceding 
12 months: filled 
prescription for 
insulin or an oral 
hypoglycemic 
agent, two fasting 
plasma glucose 
levels ≥126 mg/dl, 
two random 
MI, stroke, congestive 
heart failure (CHF), 
cardiovascular procedures, 
and revascularization 
of the lower extremity, 
deaths due to coronary, 
cerebrovascular, or 
peripheral disease: medical 
records review, ICD-9 
Major depression was associated with 
significantly higher risks of adverse 
macrovascular outcomes. 
 
Macro-vascular events developed in: 
702/2,965 without depression  
81/315 pts with minor depression 
110/443 pts with major depression 
 
  
Study)  
Major depression: 
n=443 
 
Any prior macro-
vascular event: 
Total sample: 
n=1,042 
No depression: 
n=788 
Minor depression: 
n=108 
Major depression: 
n=146 
 
(depressed 
mood or loss of 
interest)  
 
Major 
depression: at 
least 
5 positive 
symptoms 
including 1 core 
symptom 
plasma glucose 
levels ≥200 mg/dl, 
two outpatient 
diagnoses of 
diabetes, or any 
inpatient 
diagnosis  
coding  
 
Cox Proportional Hazard Models 
 
Minor depression: 
HR*=1.17 (95%CI 0.92–1.47) 
HR**=1.09 (95%CI 0.86–1.37) 
HR***=1.11 (95%CI 0.88–1.40) 
HR****=1.00 (95%CI 0.79–1.27) 
 
Major depression: 
HR*=1.20 (95%CI 0.98–1.47) 
HR**=1.13 (95%CI 0.92–1.38) 
HR***=1.49 (95%CI 1.21–1.83) 
HR****=1.25 (95%CI 1.00–1.54)  
 
*Unadjusted 
** Adjusted for any prior event 
*** Adjusted for any prior event + 
demographics 
**** Fully adjusted (DM duration, DM Tx, 
height, weight, SDSCA, HbA1c) 
  
Scherrer et 
al., 2011, 
USA18 
7 A cohort of 
people free of 
cardiovascular 
disease at 
baseline, selected 
from the Veterans 
Administration 
electronic medical 
records 
53,632 (56 years, 
12% women of 
the total sample, 
type 2) 
 
Total baseline 
sample: 
N=345,949 
MI: n=11,659 
No MI: 
n=334,290 
 
No DM/ No 
depression:  
62.1% of total 
sample 
48.3% of MI 
62.6% of No MI 
 
No 
DM/depression 
22.4% of total 
sample 
23.0% of MI 
22.4% of No MI 
 
Not 
specified 
ICD-9-CM 
codes 
ICDM-9CM 
codes or a 
prescription for 
type 2 diabetes 
medication 
MI and all course 
mortality: MI identified by 
ICD-9-CM obtained from 
Veterans Vital Status File 
Compared to people with only diabetes or 
only major depressive disorder, people with 
type 2 diabetes and MDD are at increased 
risk for new-onset MI. 
 
Incidence of MI: 
Pts with no DM or depression: 2.6%  
Pts with only depression: 3.5% 
Pts with DM only: 5.9% 
Pts with DM + depression: 7.4% 
 
Cox Proportional Hazard Models 
 
No DM/No depression: HR*=1.0 (ref) 
 
No DM/Depression: HR*=1.29 (95%CI 
1.22–1.37) 
 
DM/No depression: HR*=1.33 (95%CI 1.27–
1.40) 
 
DM/Depression: HR*=1.82 (95%CI 1.69–
1.97) 
 
*Adjusted for age, sex, race, marital status, 
insurance type 
  
DM/No depress: 
11.8% of total 
sample 
20.7% of MI 
11.5% of No MI 
 
DM/depression: 
3.7% of total 
sample 
8.0% of MI 
3.5% of No MI 
 
Sullivan et 
al., 2012, 
USA+ 
Canada32 
5 Multicenter 
randomised trial 
testing 
independent 
effects of two 
strategies of 
control of blood 
glucose, blood 
pressure, and 
lipids on CVD in 
people with type 2 
diabetes (Action 
to Control 
Cardiovascular 
Risk in Diabetes 
Health-Related 
Quality of Life 
substudy 
(ACCORD 
HRQOL)) 
 
2,053 (62 years, 
40% women, type 
2) 
 
 
Ever depressed: 
n=712 
Never depressed: 
n=1,326 
 
10 (median) PHQ-9≥10 Not reported Macro vascular composite 
outcome (major coronary 
artery disease events, 
specifically fatal events, 
nonfatal MI, and unstable 
angina): 
Not specified but assessed 
by objective criteria 
Depressive symptoms did not predict 
macrovascular composite outcome among 
people with type 2 diabetes. 
 
Cox Proportional Hazard Models 
 
Major depression:  
HR*=1.42 (95%CI 0.99–2.04) 
HR**=1.36 (95%CI 0.95–1.95) 
 
Minor depression:  
HR*=1.23 (95%CI 0.85–1.78) 
HR**=1.23 (95%CI 0.85–1.78) 
 
PHQ–9 continuous: HR*=1.02 (95%CI 1.00–
1.04) 
PHQ–9 continuous: HR**=1.02 (95%CI 
1.00–1.04) 
PHQ–9 ≥10: HR*= 1.14 (95%CI 0.88–1.49) 
PHQ–9 ≥10: HR**= 1.10 (95%CI 0.84–1.44) 
 
*Adjusted for demographics, trial, clinical 
variables 
**Adjusted for demographics, trial, clinical 
and behavioural variables 
 
Fickley et al., 
2013, USA21  
22 Prospective 
cohort study 
recruited from 
Children’s 
Hospital of 
Pittsburg registry 
of IDDM 
(Pittsburgh 
506 (27 years, 
51% women, type 
1) 
 
Age: 
No CAD: 26.7 
(6.3) 
Incident  CAD: 
No incident 
CAD 
17.9 ± 6.6 
 
Incident 
CAD 
23.6 ± 6.9 
 
BDI Hospital registry: 
childhood-onset 
(<17 years) 
IDDM and to be 
on insulin therapy 
at discharge 
CAD defined as MI 
confirmed by hospital 
records or ECG; coronary 
artery stenosis, defined as 
≥50% blockage, or 
revascularization; ischemic 
ECG, angina, diagnosed by 
a physician; or CAD death 
Baseline BDI score predicted incident CAD. 
 
BDI at baseline no CAD 5.0 (IQR 2.0–10.0 ) 
and incident CAD 6.0 (IQR 3.0–11.0), 
respectively, p=0.01. 
 
  
Epidemiology of 
Diabetes 
Complications 
study (EDC)) 
 
32.1 (6.5) 
 
Sex: 
No CAD 47.1 
(n=156) 
Incident CAD 
54.0 (n=95) 
 
(determined by a mortality 
classification committee) 
 
Ting et al., 
2013, China33 
7 Prospective 
cohort of Hong 
Kong Chinese 
with type 2 
diabetes but 
without CVD at 
baseline  
7,835: (No 
depression, 
n=7,682, 57 years 
(median), 53% 
women and 
depression n=153, 
52 years 
(median), 88% 
women, type 2) 
 
5 (median) 
[IQR=9] 
Psychiatric 
diagnosis of 
depression 
according to 
DSM-IV criteria 
Hong Kong 
diabetes registry 
CVD defined as CHD 
and/or stroke and/or 
peripheral vascular 
disease: using ICD-9 
coding  
Major depression showed a 2–3 fold 
increased risk of incident CVD, notably 
stroke, in Chinese people with type 2 DM. 
 
Total CVD outcomes (CAD, stroke, PVD):  
No depression n=798 
Depression n=31  
 
Cox Proportional Hazard Models 
 
HR*=1.68 (95%CI 1.17–2.40) 
HR**=1.94 (95%CI 1.31–2.86) 
HR***=2.18 (95% CI 1.45–3.27)  
 
*Unadjusted Model 
**Model adjusted for age, sex, smoking 
status, duration of DM, BMI, BP, HbA1c, 
lipids 
***Model adjusted for previous model + DM 
treatment 
Nefs et al., 
2015,  
The 
Netherlands19 
 Prospective 
cohort study of 
people with type 2 
diabetes in 
primary care in 
the South of the 
Netherlands 
(DiaDDZoB 
study) 
961 (No 
depression n=848; 
depression 
n=113); (age n/a, 
51% women; type 
2) 
4.8 (mean, ± 
1.3)[0.04–
5.4} 
EPDS Formal diagnosis 
of type 2 diabetes 
by General 
Practitioner 
(either a fasting 
glucose 
concentration of > 
6.9 mmol/l in 
venous plasma or 
> 6.0 mmol/l in 
capillary blood on 
two separate days, 
or an arbitrary 
glucose level > 
11.0 mmol/l in the 
presence of the 
classic 
Hospitalisation for incident 
cardiovascular event from 
PHARMO’s 
hospitalisation database 
Depression did not increase the risk of 
hopsitalisations for cardiovascular events. 
 
Total CV events:  
No depression n=72 
Depression n=6 
 
Cox Proportional Hazard Models 
 
HR*=0.62 (95%CI 0.27–1.43) 
HR**=0.68 (95%CI 0.29–1.56)  
 
*Unadjusted Model 
**Model adjusted for age and sex 
  
hyperglycemia 
symptoms), and 
receiving 
treatment for 
diabetes 
Jani et al., 
2016, UK45 
4 Cohort recruited 
from two health 
boards in the 
West of Scotland 
that serve a 
population of 
approximately 1.8 
million 
18,453 (69 years, 
41.8% women, 
n/a) 
n/a HADS-D>7 People in 
a family practice 
disease register 
with a diagnosis 
of at least one of 
CHD, diabetes, or 
stroke 
ICD-10 coding:   
1. Admission due to MI 
2. Admission due to stroke 
3. Admission due to heart 
failure (HF) 
4. Death due to CV causes 
 
Major adverse CV 
outcome (CV mortality or 
admission due to 
MI/stroke/HF) was used as 
the composite outcome 
variable.  
 
Depression predicted adverse macrovascular 
outcome in people with diabetes. 
Major adverse cardiovascular outcome 
developed in: 
1,808/18,452 participants (with or without 
depression) 
 
HR*=1.33 (95%CI 1.19–1.48) 
HR**=1.20 (95%CI 1.05–1.36) 
HR***=1.21 (95%CI 1.05–1.38) 
 
* Unadjusted 
** Adjusted for body mass index, total 
cholesterol, age, gender, socio-economic 
status, number of co-morbid conditions, and 
initiation of anti-depressants. 
*** Adjusted for body mass index, total 
cholesterol, age, gender, socio-economic 
status, number of co-morbid conditions, 
initiation of anti-depressants, and HbA1c 
Novak et al., 
2016, USA31 
6 Cohort of US 
veterans with 
diabetes.  Data 
from the Racial 
and 
Cardiovascular 
Risk Anomalies 
in CKD (RCAV) 
study 
933,211 (no 
depression 
n=592,405; 
depression n= 
340,806);( 64 
years ± 11; 3% 
women; type 1 + 
type 2) 
n/a ICD-9-CM 
codes for 
depression  or 
receiving 
antidepressant 
medication 
ICD-9 codes for 
diabetes, 
receiving any type 
of oral anti 
diabetic treatment 
or insulin, or 
having at least 
one measured 
HbA1c  >6.6% 
(46 mmol/mol) 
Incident CHD defined as 
defined as the 
composite outcome of a 
first occurrence 
of an ICD-9-CM or 
Current Procedural 
Terminology code for 
acute myocardial 
infarction, coronary artery 
bypass grafting, or 
percutaneous coronary 
intervention 
 
Incident stroke defined as 
first occurrence of ICD-9-
CM codes 
for ischemic stroke 
Depresion was associated with increased risk 
for both CHD events and stroke. 
 
Cox Proportional Hazard Models 
 
Stroke: 
HR*=1.43 (95%CI 1.39–1.46)† 
HR**=1.46 (95%CI 1.50–1.43)† 
HR***=1.32 (95%CI 1.28–1.36) 
 
CV event: 
HR*=1.49 (95%CI 1.46–1.52)† 
HR**=1.43 (95%CI 1.38–1.44)† 
HR***=1.22 (95%CI 1.19–1.24) 
 
*Unadjusted model 
**Model 1 adj for age, sex, race/ethnicity  
***Model 4 adj for age, sex, race/ethnicity, 
  
marital status, baseline eGFR, comorbidities 
at baseline (hypertension, CVD, congestive 
heart failure, cerebrovascular disease, 
peripheral vascular disease, lung disease, 
dementia, rheumatic disease, malignancy, 
HIV/AIDS, and PTSD), use of statins or 
antihypertensive medications, BMI, and 
serum albumin level 
 
†Data were obtained from the authors 
Ismail et al., 
2017, UK36 
2 People with 
diabetes from 
inner city primary 
care clinics, 
recruited within 6 
months of 
diabetes diagnosis 
1,651 (56.2 years, 
44.9% women, 
type 2) 
< 6 months PHQ-9 Medical records Any MI, coronary artery 
bypass graft 
(CABG),stroke or 
carotid/limb 
revascularization or 
amputation: derived from 
medical records 
Depressive symptoms predicted 
macrovascular composite outcome among 
people with type 2 diabetes.  
 
Macrovascular events developed in: 
30/1,077 pts without depression 
10/170 pts with depressive symptoms 
 
OR*=2.18 (95%CI 1.05–4.55) 
OR**=2.78 (95%CI 1.19–6.49) 
OR***=2.29 (95%CI 0.88–5.95) 
 
*Unadjusted 
** Adjusted for age, sex, non-white ethnicity, 
baseline BMI, baseline systolic BP, baseline 
smoking status, baseline serum cholesterol, 
baseline HbA1c, prescription of oral 
hypoglycaemic medication at 2 years, and 
prescription of insulin at 2 years 
*** Fully adjusted for age, sex, non-white 
ethnicity, baseline BMI, baseline systolic BP, 
baseline smoking status, baseline serum 
cholesterol, baseline HbA1c, prescription of 
oral hypoglycaemic medication at 2 years, 
prescription of insulin at 2 years and baseline 
IL-1RA concentration (natural log-
transformed) 
 
  
  
 
Supplementary Table 1B. Depression to microvascular complications (Overview of all included studies sorted by publication date in ascending order) 
 
Author, year, 
country 
Follow-
up  
(years) 
Study design and 
population 
Number of 
participants 
(mean age, sex, 
type of diabetes) 
Diabetes  
Duration 
(mean±SD) 
[range] 
Depression 
assessment  
Diabetes 
assessment  
Complication: assessment  Major findings 
Black et al., 
2003, USA16 
7 
 
5  
for 
“Lifetim
e major 
depressi
on or 
dysthymi
a” 
Longitudinal 
population based 
study of Mexican 
Americans 
residing in the 
South Western 
USA (EPESE) 
 
636 out of 2,830 
(≥ 65 years, 59% 
women, type 2) 
 
“No depression” 
(CESD=0) 
n=79 
 
“Minimal 
depression” 
(CESD=1-15) 
n=369 
 
“Minor 
depression” 
(CESD≥16) 
n=188 
 
“Lifetime major 
depression or 
dysthymia” 
n=52/453 
 
n/a CES-D≥16 or 
clinical 
diagnostic 
criteria (CIDI), 
DSM-IV 
Self-report  Nephropathy, retinopathy, 
neuropathy: based on self-
report 
Compared to reference group of people 
without DM or depression, having T2DM 
and depression predicted increased incidence 
of microvascular events. 
 
Cox Proportional Hazard Models 
 
“Minimal depression”: HR*=2.43 (95%CI 
1.90–3.14); 
 
“Minor depression”: HR*=8.63 (95%CI 
5.40–13.79) 
 
“Lifetime major depression or dysthymia”: 
HR*=11.32 (95%CI 8.76–15.43) 
 
*Adjusted for age, sex, education, 
acculturation, marital status  
 
Roy et al., 
2007b, USA30 
6 Longitudinal 
study of African-
American  people 
with type 1 
diabetes admitted 
to hospitals in 
New Jersey 
483 (BDI>14 
n=51, 33 years 
61% women and 
BDI≤14 n=264, 
29 years, 57% 
women, type 1) 
11.0 ± 8.5 BDI>14 Medical records Retinopathy: by color 
fundus photography graded 
in a blinded fashion using 
the Airlie House 
classification  
Depression is significantly associated with 
poor glycaemic control and higher 
progression of proliferative diabetic 
retinopathy in African Americans with type 
1 diabetes. 
 
Diabetes retinopathy:  
OR*=3.04 (95%CI 1.39–6.65) 
OR**=2.44 (95%CI 1.01–5.88) 
 
Proliferative diabetic retinopathy:  
OR*=3.41 (95%CI 1.64–7.11) 
OR**=3.19 (95%CI 1.30–7.87) 
 
*Univariate 
** Adjusted for glycosylated Hb (per 1%), 
diabetes duration (per 1 year) and Systemic 
  
hypertension 
 
 
Gonzalez et 
al, 2010, UK 
+ USA41  
1.5 A prospective 
cohort study of 
people with 
diabetes at high 
risk for foot 
ulceration 
attending three 
sites for diabetes 
treatment in the 
UK or USA  
 
333 (62 years, 
29% women, type 
1 and type 2 
[73%]) 
17.0 ± 11.5 HADS 
 
Medical records 
 
Defined as a full-thickness 
skin break below the 
malleolus (foot-ankle 
junction): History and 
follow-up evaluations of 
foot ulcer by self-report, 
baseline and each follow-up 
visit by medical 
examination 
Depression predicted the risk of developing 
first foot ulcers, but not recurrent diabetic 
foot ulcers. 
 
Cox Proportional Hazard Model 
 
Incident foot ulcers HR*=1.68, 95% (95%CI 
1.20–2.35) 
Recurrent foot ulcers HR*=0.88 (95%CI 
0.61–1.27) 
 
*Adjusted for Retinopathy, VPT, foot self-
care 
Lin et al., 
2010, USA17  
5 Longitudinal 
cohort study of 
people with type 2 
diabetes in 
primary care 
clinics in Western 
Washington state, 
USA (Pathways 
Epidemiology 
Study) 
3,723 (64 years, 
48% women, type 
2) 
 
No depression: 
n=2,965 
Minor depression: 
n=315 
Major depression: 
n=443 
 
Any prior micro-
vascular event: 
Total sample: 
N=750 
No depression: 
n=580 
Minor depression: 
n=77 
Major depression: 
n=93 
8.8 ± 8.4 
 
PHQ-9 
algorithm 
 
Minor 
depression:  
2-4 positive 
symptoms 
including 1 core 
symptom 
(depressed 
mood or loss of 
interest)  
 
Major 
depression: at 
least 
5 positive 
symptoms 
including 1 core 
symptom 
In the preceding 
12 months: filled 
prescription for 
insulin or an oral 
hypoglycemic 
agent, two fasting 
plasma glucose 
levels ≥126 
mg/dl, two 
random plasma 
glucose levels 
≥200 mg/dl, two 
outpatient 
diagnoses of 
diabetes, or any 
inpatient 
diagnosis  
End-stage renal disease, low 
vision or blindness, 
proliferative retinopathy or 
photocoagulation 
procedures for diabetes, and 
foot ulcers: using medical 
records review, ICD-9 
coding  
Major depression was associated with 
significantly higher risks of adverse 
microvascular outcomes. 
 
Micro-vascular events  developed in: 
394/2,965 pts without depression  
59/315 pts with minor depression 
80/443 pts with major depression 
 
Cox Proportional Hazard Models 
 
Minor depression: 
HR*=1.54 (95%CI 1.16–2.03) 
HR**=1.49 (95%CI 1.13–1.97) 
HR***=1.48 (95%CI 1.11–1.95) 
HR****=1.31 (95%CI 0.98–1.74) 
 
Major depression: 
HR*=1.48 (95%CI 1.16–2.03) 
HR**=1.47 (95%CI 1.15–1.87) 
HR***=1.67 (95%CI 1.30–2.15) 
HR****=1.36 (95%CI 1.05–1.76)  
 
*Unadjusted 
** Adjusted for any prior event 
*** Adjusted for any prior event + 
demographics 
**** Fully adjusted (any prior event, 
demographics, DM duration, DM Tx, height, 
weight, SDSCA, HbA1c) 
 
  
Williams et 
al., 2010, 
USA27  
4.1 Longitudinal 
cohort study of 
people with type 2 
diabetes without 
prior diabetic foot 
ulcers or 
amputations from 
primary care 
clinics in Western 
Washington state, 
USA (Pathways 
Epidemiology 
Study) 
 
3,474 (64 years, 
48% women, type 
2) 
8.5 ± 8.2 PHQ-9 In the preceding 
12 months: filled 
prescription for 
insulin or an oral 
hypoglycemic 
agent, two fasting 
plasma glucose 
levels ≥126 
mg/dl, two 
random plasma 
glucose levels 
≥200 mg/dl, two 
outpatient 
diagnoses of 
diabetes, or any 
inpatient 
diagnosis 
Diabetic foot ulcer: first 
screened using ICD-9 
diagnosis codes; diagnosis 
confirmed by chart review 
Compared to people without depression, 
people with major depression had a 2–fold 
increase in the risk of incident diabetic foot 
ulcers, whereas minor depression was not 
associated with incident diabetic foot ulcers. 
 
Cox Proportional Hazard Models 
 
Major depression HR*=2.00 (95% CI, 1.24–
3.25) 
Minor depression HR*=1.37 (95% CI, 0.77–
2.44) 
 
*Fully adjusted model: sociodemographic 
characteristics, medical comorbidity, 
glycosylated hemoglobin, diabetes duration, 
insulin use, number of diabetes 
complications, body mass index, smoking 
status, and foot self-care 
 
Sieu et al., 
2011, USA26  
5 Longitudinal 
cohort study of 
people with type 2 
diabetes from 
primary care 
clinics in Western 
Washington state, 
USA (Pathways 
Epidemiology 
Study) 
2,359 (64 years, 
48% women, type 
2) 
8.1 ± 8.1 
 
PHQ-9 In the preceding 
12 months: filled 
prescription for 
insulin or an oral 
hypoglycemic 
agent, two fasting 
plasma glucose 
levels ≥126 
mg/dl, two 
random plasma 
glucose levels 
≥200 mg/dl, two 
outpatient 
diagnoses of 
diabetes, or any 
inpatient 
diagnosis 
Incident retinopathy: retinal 
evaluation by an optometrist 
or an ophthalmologist and 
had ICD-9 codes  
People with diabetes and comorbid 
depression had a significantly higher risk of 
developing diabetic retinopathy. 
 
Logistic Regression Model 
 
OR*=1.026 (95%CI 1.002–1.051) 
 
Depressive symptoms were associated with 
time to incident retinopathy. 
 
Cox Proportional Hazard Model 
 
HR*=1.025 (95%CI 1.009–1.041) 
 
*Adjusted for length of follow-up, 
sociodemographic characteristics, baseline 
clinical characteristics, and health 
behaviours 
Sullivan et 
al., 2012, 
USA + 
Canada32 
5 Multicenter 
randomized trial 
testing the effects 
of two strategies 
of control of 
blood glucose, 
blood pressure, 
and lipids on 
2,053 (62 years, 
40% women, type 
2) 
 
 
 
Ever depressed: 
n=712 
10 (median) PHQ-9 and 
PHQ-9≥10 
Not reported Composite micro vascular 
outcome (fatal or nonfatal 
renal failure or retinal 
photocoagulation or 
vitrectomy for diabetic 
retinopathy): Not specified 
 
Assessed by objective 
Depressive symptoms did not predict 
microvascular composite outcome among 
people with type 2 diabetes. 
 
Cox Proportional Hazard Models 
 
Major depression:  
HR*=0.93 (95%CI 0.53–1.62)  
  
CVD in people 
with diabetes 
(Action to Control 
Cardiovascular 
Risk in Diabetes 
Health-Related 
Quality of Life 
substudy; 
ACCORD 
HRQOL) 
 
Never depressed: 
n=1,326 
 
criteria HR**=0.97(95%CI 0.56–1.70) 
 
Minor depression: 
HR*=1.14 (95%CI 0.70–1.85) 
HR**=1.14 (95%CI 0.70–1.86) 
 
PHQ-9 continuous: HR*=1.01 (95%CI 
0.98–1.04) 
PHQ-9 continuous: HR**=1.01 (95%CI 
0.99–1.04) 
PHQ-9 ≥10: HR*=1.27 (95%CI 0.90–1.80) 
PHQ-9 ≥10: HR**=1.31 (95%CI 0.93–1.86) 
 
*Adjusted for demographic, trial, clinical 
variables 
**Adjusted for demographic, trial, clinical 
and behavioural variables 
 
Yu et al., 
2015, USA28  
10 Longitudinal 
cohort study of 
people with type 2 
diabetes from 
primary care 
clinics in Western 
Washington state, 
USA (Pathways 
Epidemiology 
Study) 
3,886, 63 years, 
48% women, type 
1 + type 2) 
 
(No depression 
n=3,111; 
major depressive 
symptoms n=448;  
minor depressive 
symptoms n=327)  
6.3 [3–15] PHQ-9≥10 and 
major 
depression using 
PHQ-9 
algorithm 
 
Group Health 
Diabetes Registry 
ESRD requiring dialysis or 
kidney transplant based on 
ICD-9 codes 
Major but not minor depressive symptoms 
were associated with a higher risk of 
incident end stage renal disease. 
 
Cox Proportional Hazard Models 
 
HR*=2.31 (95%CI 0.71–2.89) 
HR**=1.90 (95%CI 1.09–3.32) 
HR***=1.85 (95%CI 1.02–3.33)  
 
*Unadjusted 
**Model 1: Adjusted for age, sex, 
race/ethnicity, marital status, education 
level, smoking status, body mass index, 
duration of diabetes, hemoglobin A1c, 
eGFR, presence of baseline 
microalbuminuria, hypertension, and 
ACEI/ARB use 
***Model 2: Model 1 + diabetes self-care 
activities 
Novak et al., 
2016, 
USA31 
6 Cohort of US 
veterans within 
diabetes.  Data 
from the Racial 
and 
Cardiovascular 
Risk Anomalies 
933,211 (no 
depression 
n=592,405; 
depression n= 
340,806; 64 years 
± 11; 3% women; 
type 1 + type 2) 
n/a ICD-9-CM 
codes for 
depression  or 
receiving 
antidepressant 
medication 
ICD-9 codes for 
diabetes, 
receiving any 
type of oral anti 
diabetic treatment 
or insulin, or 
having at least 
Incident CKD was defined 
as having two eGFR levels 
<60 mL/min/1.73 m2 
separated by ≥ 90 days after 
the enrollment period and a 
>25% decline from baseline 
eGFR 
Depression was associated with increased 
risk for chronic kidney disease in people 
with diabetes. 
 
Cox Proportional Hazard Models 
 
  
in CKD (RCAV) 
study 
one measured 
HbA1c  >6.6% 
(46 mmol/mol) 
 HR*=1.19 (95%CI 1.18–1.21) 
HR**=1.36 (95%CI 1.35–1.38) † 
HR***=1.18 (95%CI 1.17–1.20) 
 
*Unadjusted model 
**Model 1 adj for age, sex, race/ethinity  
***Model 4 adj for age, sex, race/ethnicity, 
marital status, baseline eGFR, comorbidities 
at baseline (hypertension, CVD, congestive 
heart failure, cerebrovascular disease, 
peripheral vascular disease, lung disease, 
dementia, rheumatic disease, malignancy, 
HIV/AIDS, and PTSD), use of statins or 
antihypertensive medications, BMI, and 
serum albumin level 
 
†Data were obtained from the authors 
Iversen et al., 
2015, 
Norway43 
11 Community based 
longitudinal study 
including 
residents of Nord-
Trøndelag county 
(the Nord-
Trøndelag Health 
Study)  
1,415 out of 
36,031 (55 years, 
49% women, type 
n/a) 
5.0  
[0–12] 
HADS≥8 or ≥11 Self-report 
followed by 
fasting blood 
glucose sample 
Self-report  Symptoms of depression at baseline were 
associated with an increased risk of a 
diabetic foot ulcer in a dose response 
manner during this 11-year follow-up. 
Where HADS-D was measured as a 
continuous variable, results showed an 
approximately 10% increase for each unit 
increase in HADS-D. 
 
Logistic Regression Analyses 
 
Compared to people with a HADS-D score 
<8, 
HADS-D score 8–10: OR*=1.95 (95%CI 
1.02–3.74) 
HADS-D scores ≥ 11: OR*=3.06 (95%CI 
1.24– 7.54) 
HADS-D as a continuous variable: 
OR*=1.11 (95% CI 1.04–1.18). 
 
*Adjusted for age, sex, and serum glucose 
Ismail et al., 
2017, UK36 
2 People with 
diabetes from 
Inner city primary 
care clinics, 
recruited within 6 
months of 
1,651 (56.2 years, 
44.9% women, 
type 2) 
< 6 months PHQ-9 Medical records Neuropathy: assessed 
clinically at  each study visit 
by neurothesiometry 
vibration perception 
threshold ≥25 V  
Nephropathy, retinopathy: 
Depressive symptoms did not predict 
microvascular composite outcome among 
people with type 2 diabetes.  
 
Microvascular events developed in: 
333/1,155 pts without depression 
  
diabetes diagnosis derived from medical 
records 
55/179 pts with depressive symptoms 
 
OR*=1.10 (95%CI 0.78–1.54) 
OR**=1.33 (95%CI 0.90–1.96) 
OR***=1.32 (95%CI 0.85–2.05) 
 
*Unadjusted 
** Adjusted for age, sex, non-white 
ethnicity, baseline BMI, baseline systolic 
BP, baseline smoking status, baseline serum 
cholesterol, baseline HbA1c, prescription of 
oral hypoglycaemic medication at 2 years, 
and prescription of insulin at 2 years 
*** Fully adjusted for age, sex, non-white 
ethnicity, baseline BMI, baseline systolic 
BP, baseline smoking status, baseline serum 
cholesterol, baseline HbA1c, prescription of 
oral hypoglycaemic medication at 2 years, 
prescription of insulin at 2 years and 
baseline IL-1RA concentration (natural log-
transformed) 
 
Trento et al., 
2017, Italy35 
8 Observational 
prospective study 
of people with 
tyoe 2 diabetes 
were enrolled in 
an  
498 (477 where 
baseline fundus 
photos were 
available; age n/a, 
% women n/a, 
type 2) 
n/a Zung Self 
Rating Scale 
>60 
n/a Fundus examination was by 
2-field, 45° digital colour 
photography, 
Retinopathy was classified 
as absent if corresponding 
to Early Treatment Diabetic 
Retinopathy Study 
(ETDRS) standard 10, mild 
if doubtful or ETDRS = 20, 
and moderate or more 
severe if ETDRS ≥35  
Depressive symptoms were not associated 
with higher risks of retinopathy. No data 
provided. 
 
 
Supplementary Table 1C. Complications to depression (Overview of all included studies sorted by publication date in ascending order) 
 
Author, year, 
country 
Follow-
up  
(years) 
Study design 
and population 
Number of 
participants 
(mean age, sex, 
type of diabetes) 
Diabetes  
Duration 
(mean±SD
) 
[range] 
Depression 
assessment  
Diabetes 
assessment  
Complication: assessment  Major findings 
Katon et al., 
2009, USA40  
5 Longitudinal 
cohort study of 
2,759 (55% age > 
60 years, 49% 
9.0 ± 6.0 PHQ-9 
(dichotomous: 5 
In the preceding 
12 months: filled 
Macro- or microvascular 
events or coronary, 
Macrovascular events or procedures (with the 
exception of stroke) were significant 
  
people with type 
2 diabetes from 
primary care 
clinics in Western 
Washington state, 
USA (Pathways 
Epidemiology 
Study) 
women, type 1 and 
type 2 [95%]) 
to 9 or ≥ 10 and 
a continuous 
severity score) 
 
prescription for 
insulin or an oral 
hypoglycemic 
agent, two fasting 
plasma glucose 
levels ≥126 mg/dl, 
two random 
plasma glucose 
levels ≥200 mg/dl, 
two outpatient 
diagnoses of 
diabetes, or any 
inpatient diagnosis 
cerebrovascular or 
peripheral vascular 
procedures: were derived 
from automated data ICD-9 
and CPT codes 
predictors of depression, whereas 
microvascular events were not. 
 
Major depressive symptoms developed in: 
20/202 pts who had a coronary procedure 
17/393 pts who had retinopathy 
33/550 pts who had nephropathy 
 
Logistic Regression Analyses 
Coronary procedures: OR*=1.92 (95%CI 
1.14–3.25) 
 
Stroke: OR*=1.75 (95%CI 0.83–3.67) 
 
No. of macrovascular events or procedures: 
OR*=1.39 (95%CI 1.02–1.88) 
 
 
Retinopathy: OR*=0.69 (95%CI 0.40–1.21) 
 
Nephropathy: OR*=1.06 (95%CI 0.65–1.71) 
 
No. of microvascular events: OR*=0.88 
(95%CI 0.64–1.21) 
 
*Adjusted for non-response probability and 
PHQ-9 score groups at baseline 
 
Vileikyte et 
al., 2009, UK 
+ USA39  
1.5 A prospective 
cohort study of 
people with 
diabetes and 
diabetic 
peripheral 
neuropathy 
attending three 
sites for diabetes 
treatment in the 
UK or USA 
338 (61 years, 29% 
women, type 1 and 
type 2 [73%]) 
Not 
specified 
HADS Not specified 
 
Diabetic peripheral 
neuropathy: severity defined 
as vibration perception 
threshold >25V and 
neuropathy disability score 
>3; neuropathy symptoms 
assessed by the Neuropathy 
and Foot Ulcer-specific 
quality of Life Instrument 
(NeuroQol) 
Neuropathy was a risk factor for depressive 
symptoms because it generates pain and 
unsteadiness. 
 
Multivariate Regression Model 
 
β*=.56 (p<0.001) 
β**=.56 (p<0.001) 
 
*Model adjusted for baseline HADS-D and 
demographic/disease variables. 
**Model 5 adjusted for baseline HADS-D, 
demographic/disease variables, baseline DPN 
severity, baseline DPN symptoms, and 
change in DPN symptoms 
 
Pan et al., 
2012, 
Taiwan42 
8 Population-based 
follow-up study 
of elderly people.  
144,216 (72.5 
years, 49.5% 
women, type n/a) 
0 years ICD-9-CM 
criteria 
ICD-9-CM criteria ICD-9-CM criteria Macrovascular complications increased the 
risk of depression onset, with a larger number 
of complications predicting higher risk of 
  
depression onset. 
 
Depression developed in: 
6,124/119,040 pts without complications 
541/12,996 pts with stroke 
678/12,488 pts with CVD 
 
Cox Proportional Hazard Models 
 
Stroke: 
HR*=1.16 (95%CI 1.06–1.27) 
HR**=0.99 (95%CI 0.90–1.09) 
HR***=0.99 (95%CI 0.90–1.09) 
 
CVD: 
HR*=1.36 (95%CI 1.26–1.47) 
HR**=1.21 (95%CI 1.11–1.32) 
HR***=1.13 (95%CI 1.04–1.23) 
 
*Unadjusted 
**Model 1 adjusted for age, sex, urbanization 
status, major illness, and other macrovascular 
complications / hip fracture 
***Model 2 adjusted for Model 1 + number 
of outpatient visits during 2000-2001 
 
Jacob & 
Kostev, 2016, 
Germany34 
1–10 People with 
newly diagnosed 
type 2 diabetes, 
identified through 
General 
Practitioner 
databases 
90,412 (65.5 years, 
49.8% women, 
type 2) 
Newly 
diagnosed  
ICD-10 ICD-10 ICD-10 Incident depression was predicted by the 
following complications: 
 
Retinopathy HR*=1.44 (95%CI 1.21–1.70)  
Neuropathy HR*=1.25 (95%CI 1.17–1.33)  
Nephropathy HR*=1.13 (95%CI 1.06–1.21) 
CHD HR*=1.11 (95%CI 1.05–1.17) 
Stroke HR*=1.18 (95%CI 1.09–1.27) 
 
But not predicted by: 
peripheral vascular disease HR*= 1.03 
(95%CI 0.94-1.13)† 
myocardial infarction, HR*=1.02 (95%CI 
0.90-1.16)† 
 
*Multivariate Cox proportional hazards 
models, adjusted for sex, private insurance, 
diabetes complications, co-diagnoses and 
  
prescriptions. 
†Data were obtained from the authors 
 
Bell et al., 
2017, Puerto 
Rico44 
4 Longitudinal 
population-based 
sample of adults 
aged 60 years and 
over for the 
Puerto Rican 
Elderly: Health 
Conditions study 
(PREHCO) 
480 (69.12 years, 
59.8% female, type  
n/a) 
n/a GDS Self-report Self-report: 
Diabetes-related 
complications were 
measured as a summed 
index score of history of 
problems with circulation, 
vision, foot sores, 
amputations, and kidney 
disease due to diabetes 
(range 0–4) 
Diabetes-related complications were related 
to greater odds of incident depressive 
symptoms. 
 
OR*=1.46 (95%CI 1.14–1.86) 
 
*Logistic regression model that included age, 
gender, education, vascular comorbidity, 
diabetes complications, cognitive decline, 
and baseline cognitive performance. 
Deschênes et 
al., 2017, 
Canada37 
5 Prospective 
cohort study from 
a community 
sample in 
Montreal, Canada 
1,314 (age n/a, 
52.2% women, 
type 1 and type2) 
n/a PHQ-9 
algorithm 
Self-report Self-report The number of diabetes complications at 
baseline was associated with greater risk of 
elevated depressive symptoms. 
Macrovascular complications were 
associated with higher risk of depression, 
whereas within microvascular symptoms an 
association was found for neuropathy, but not 
foot problems or eye problems. 
 
Depression developed in: 
34/429 pts without complications 
66/338 pts with CAD 
43/163 pts with CVD 
89/537 pts with PVD 
71/374pts with neuropathy 
13/79 pts with foot problems 
37/260 pts with eye problems 
 
CAD: 
RR*=1.85 (95%CI 1.39–2.46) 
RR**=1.76 (95%CI 1.32–2.35) 
 
CVD: 
RR*=2.41 (95%CI 1.78–3.27) 
RR**=2.22 (95%CI 1.59–3.10) 
 
PVD: 
RR*=1.61 (95%CI 1.21–2.13) 
RR**=2.36 (95%CI 1.00–1.83) 
 
Neuropathy: 
RR*=2.82 (95%CI 1.37–2.41) 
RR**=1.65 (95%CI 1.22–2.23) 
 
Foot problems: 
  
RR*=1.30 (95%CI 0.78–2.19) 
RR**=1.10 (95%CI 0.63–1.92) 
 
Eye problems: 
RR*=1.14 (95%CI 0.81–1.59) 
RR**=1.05 (95%CI 0.72–1.53) 
 
*Unadjusted 
**Model 2 adjusted for age, sex, ethnicity, 
education, marital status, BMI category, 
smoking frequency, insulin use within the 
past month, and self-rated diabetes control 
Ab-OxLDL=antibody to oxidized low-density lipoprotein; BDI=Beck’s depression inventory; BMI=body mass index; BP=blood pressure; CABG=coronary artery bypass graft; CAD=coronary artery disease; 
CESD=center for epidemiologic studies depression; scale; CHD=coronary heart disease; CHF=congestive heart failure; CI=confidence interval; CIDI=Composite International Diagnostic Interview; CKD=chronic 
kidney disease; CPT= current procedural terminology; CVD=cerebrovascular disease; DM=diabetes mellitus; DPN=diabetic peripheral neuropathy; DSM-III=Diagnostic and Statistical Manual of Mental Disorders, 
3rd Edition; DSM-IV=Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; ECG=electrocardiogram; eGFR=estimated glomerular filtration rate; ESRD=end stage renal disease; HADS=hospital anxiety 
and depression scale; HbA1c= glycated hemoglobin; HDL=high density lipoprotein; HR=hazard ratio; ICD-9=international statistical classification of diseases and related health problems; IDDM=insulin dependent 
diabetes mellitus; LDL=low density lipoprotein; LEAD=lower-extremity arterial disease; MDD=major depressive disorder; MI=myocardial infarction; n/a= not available; OR=odds ratio; PHQ-9=Patient Health 
Questionnaire-9; PTSD=post traumatic stress disorder; PVD=peripheral vascular disease; RR=relative risk; SDSCA=summary of diabetes self-care activities; SE=standard error; Tx=treatment 
 
Results in BOLD represent the models selected for the meta-analysis. 
 
 
 
